2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Humming bird sign in craniovertebral junction anomaly leading to misdiagnosis of progressive supranuclear palsy

D. Desai, D. Pandya, S. Desai (Anand, India)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease

D. Roos, J. Twisk, P. Raijmakers, R. Doty, H. Berendse (Amsterdam, Netherlands)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Identification and Characterization of Selective and High Affinity Small Molecules as Positron Emission Tomography (PET) Imaging Tracers for Pathological Alpha-Synuclein

E. Tsika, E. Vokali, J. Molette, M. Ravache, P. Rodriguez, V. Darmency, K. Piorkowska, S. Poli, H. Kroth, F. Capotosti, D. Lowe, J. Stoehr, M. Kosco-Vilbois, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Identifying altered resting state network connectivity in Parkinson’s disease with mild cognitive impairment

J. Yang, K. Mcmahon, D. Copland, G. Byrne, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study

R. Lawson, S. Richardson, A. Yarnall, D. Burn, L. Allan (Newcastle Upon Tyne, United Kingdom)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Imaging biomarker for progression of motor symptoms in advanced Parkinson’s disease

K. Furukawa, N. Sawamoto, A. Shima, D. Kambe, A. Nishida, I. Wada, H. Sakamaki, K. Yoshimura, Y. Fushimi, T. Okada, K. Togashi, R. Takahashi (Kyoto, Japan)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Imaging Brain Insulin Resistance in Parkinson’s Disease using [¹⁸F]FDG-PET

E. Hogg, P. Linesch, T. Wu, E. Tan, Z. Fan, W. Gao, A. Waxman, M. Tagliati (Los Angeles, CA, USA)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

Neuroimaging · Les Muses Terrace, Level 3